Back to Companies
Adaptimmune Therapeutics PLC
ADAPOTCCIK: 0001621227
Recent Form 4 activity at Adaptimmune Therapeutics PLC (ADAP) spans 5 filings across 5 insiders (all of them on the sell side). Purchases total $0 against $7.1M in sales — heavily weighted toward selling, for net sales of $7.1M. EcoR1 Capital, LLC (10% Owner) is the most active by dollar volume, and the single largest transaction was $6.9M by EcoR1 Capital, LLC. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$7.1M
Purchases
$0
Sales
$7.1M
Unique Insiders
5
Recent Insider Trades
5 loaded
| Oct 8 | ADAP Adaptimmune Therapeutics PLC | Hill Christopher James | Chief Financial Officer | Other | $0 |
| Sep 3 | ADAP Adaptimmune Therapeutics PLC | Wood Gavin | Chief Financial Officer | Sell | $950 |
| Aug 29 | ADAP Adaptimmune Therapeutics PLC | Bertrand William C JR | Chief Operating Officer | Sell | $2.1K |
| Aug 19 | ADAP Adaptimmune Therapeutics PLC | Behbahani Ali | Insider | Sell | $229.2K |
| Jul 30 | ADAP Adaptimmune Therapeutics PLC | EcoR1 Capital, LLC | 10% Owner | Sell | $6.9M |
5 filings